Stay updated on Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page

  1. Check
    12 days ago
    No Change Detected
  2. Check
    19 days ago
    Change Detected
    Summary
    Footer updates include the addition of Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link as well as the Revision: v3.3.2 reference. These changes do not affect the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T08:23:23.000Z thumbnail image
  3. Check
    26 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    The page revision changed from v3.3.1 to v3.3.2; no study content or critical elements were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:06:11.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T13:43:03.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The temporary operating-status notice about government funding was removed. Core study information and links remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:29:13.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The Outcome Measures section has been expanded to show current and original endpoints (PFS, OS, ORR, Clinical Benefit Rate, Duration of Response) with detailed definitions. This adds more detail on how outcomes are measured and the time frames for analysis.
    Difference
    0.1%
    Check dated 2025-11-03T01:10:26.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Update introduces a government-status notice and a new software version (v3.2.0), replacing the previous v3.1.0 mention.
    Difference
    4%
    Check dated 2025-10-05T10:11:47.000Z thumbnail image

Stay in the know with updates to Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib vs Lapatinib/Capecitabine in Advanced Breast Cancer Clinical Trial page.